Woman Re-Prescribed Benzodiazepines in Prison Despite Recent Addiction

A woman named Lianne was prescribed benzodiazepines while in prison shortly after completing a difficult detoxification process for the same class of drugs, according to an investigation by Pointer | KRO-NCRV. The medication was issued by prison medical staff who did not review her history of addiction before providing the prescriptions.

Lianne had previously struggled with a severe addiction to benzodiazepines, a group of sedative medications often used to treat anxiety and insomnia. Prior to her imprisonment, she had undergone an arduous process to detox from the substances, aiming to eliminate the drugs from her system and break the cycle of dependency.

Medical Oversight in Detention

Upon entering the prison system, Lianne was again prescribed benzodiazepines. She reported that the medical personnel responsible for her care in the facility did not conduct a thorough screening of her medical background or consult her previous healthcare providers regarding her history of substance abuse.

The lack of coordination between external healthcare providers and the prison’s medical department meant that the staff were unaware that Lianne had recently fought to overcome an addiction to the very drugs they were administering.

Nobody checked my addiction history.

Lianne

Lianne stated that this failure in the intake process effectively reset her progress, forcing her back into a dependency that she had spent significant effort to escape. The re-introduction of the medication in a controlled environment like a prison cell created a situation where her previous struggles with addiction were ignored by the institutional healthcare system.

Systemic Failures in Healthcare Handover

The investigation by Pointer | KRO-NCRV highlights a systemic gap in the handover of medical information when individuals transition from community care to correctional facilities. In many cases, the medical files of inmates are not fully integrated or reviewed with the necessary detail to prevent the prescription of high-risk medications to vulnerable populations.

Benzodiazepines are recognized for their high potential for physical and psychological dependence. When prescribed without a comprehensive understanding of a patient’s history, there is a significant risk of relapse or the exacerbation of existing addiction disorders.

The report suggests that the pressure on prison medical services and the fragmented nature of health data sharing contribute to these oversights. When medical staff rely on brief intake interviews or incomplete records, critical information regarding a patient’s addiction history can be missed.

Risks of Benzodiazepine Use in Prisons

The use of benzodiazepines within correctional settings is a subject of concern due to the potential for misuse and the severity of withdrawal symptoms. Abrupt cessation of these drugs can lead to serious health complications, including seizures and extreme anxiety, which can be difficult to manage in a prison environment.

For individuals like Lianne, who have already experienced the trauma of addiction and the difficulty of withdrawal, the accidental re-prescription of these drugs can lead to profound psychological distress. The prison environment, characterized by stress and limited autonomy, can further complicate the recovery process for those struggling with substance use disorders.

Pointer | KRO-NCRV’s findings indicate that the failure to implement rigorous screening protocols for addictive medications in prisons can leave inmates susceptible to medical errors that jeopardize their long-term health and recovery goals.

The case serves as an example of the need for better communication between the public health sector and the correctional health system to ensure that a patient’s medical history follows them into detention, preventing the recurrence of avoidable medical crises.